Biohaven Pharmaceutical Holding Co Ltd. – Underwriting Agreements – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Underwriting Agreements Filter

from 8-K 47 pages 2,686,409 Shares Biohaven Pharmaceutical Holding Company Ltd. Common Shares, Without Par Value Underwriting Agreement

from 8-K 86 pages Agreement and Plan of Merger by and Among Biohaven Pharmaceutical Holding Company, Ltd., Biohaven Therapeutics Ltd., Kleo Acquisition, Inc., Kleo Pharmaceuticals, Inc. and Shareholder Representative Services LLC, as the Stockholders’ Representative Dated as of January 1, 2021

from 8-K 46 pages Biohaven Pharmaceutical Holding Company Ltd. Common Shares (Without Par Value) Having an Aggregate Offering Price of Up to $400,000,000 Equity Distribution Agreement

from 8-K 39 pages 4,830,917 Shares Biohaven Pharmaceutical Holding Company Ltd. Common Shares, Without Par Value Underwriting Agreement

from 8-K 43 pages 6,976,745 Shares Biohaven Pharmaceutical Holding Company Ltd. Common Shares, Without Par Value Underwriting Agreement

from S-1 43 pages [●] Shares Biohaven Pharmaceutical Holding Company Ltd. Common Shares, Without Par Value Underwriting Agreement

from S-1/A 39 pages Shares Biohaven Pharmaceutical Holding Company Ltd. Common Shares, Without Par Value Underwriting Agreement